APA (7th ed.) Citation

M, C., M, B., E, S., DJ, S., & SH, G. (2024). Predictable excess hepatotoxicity in the SimpliciTB trial - Authors' reply. The Lancet. Infectious diseases, 24(12), e728. https://doi.org/10.1016/S1473-3099(24)00718-7

Chicago Style (17th ed.) Citation

M, Cevik, Beumont M, Sun E, Sloan DJ, and Gillespie SH. "Predictable Excess Hepatotoxicity in the SimpliciTB Trial - Authors' Reply." The Lancet. Infectious Diseases 24, no. 12 (2024): e728. https://doi.org/10.1016/S1473-3099(24)00718-7.

MLA (9th ed.) Citation

M, Cevik, et al. "Predictable Excess Hepatotoxicity in the SimpliciTB Trial - Authors' Reply." The Lancet. Infectious Diseases, vol. 24, no. 12, 2024, p. e728, https://doi.org/10.1016/S1473-3099(24)00718-7.